Mortality after kidney transplantation: 10-year outcomes

Basit Öğe Kaydı
dc.authoridtoplu, sibel altunışık/0000-0002-2915-4666
dc.authoridSahin, Idris/0000-0002-8683-3737
dc.authoridulutas, ozkan/0000-0002-2155-8340
dc.authorwosidYıldırım, İsmail Okan/AFR-8243-2022
dc.authorwosidPiskin, Turgut/HKV-8614-2023
dc.authorwosidtoplu, sibel altunışık/ABH-5816-2020
dc.authorwosidSahin, Idris/AAS-4390-2020
dc.authorwosidulutas, ozkan/ABI-6332-2020
dc.contributor.authorPiskin, Turgut
dc.contributor.authorSimsek, Arife
dc.contributor.authorMurat-Dogan, Sait
dc.contributor.authorDemirbas, Baha T.
dc.contributor.authorUnal, Bulent
dc.contributor.authorYildirim, Ismail O.
dc.contributor.authorToplu, Sibel A.
dc.date.accessioned2024-08-04T20:51:48Z
dc.date.available2024-08-04T20:51:48Z
dc.date.issued2022
dc.departmentİnönü Üniversitesien_US
dc.description.abstractObjectives: In the past decade, advances in immunological therapy have increased the survival of kidney recipients and their grafts. However, it has not achieved the desired level of improvement. This study aims to reveal the mortality among kidney recipients. Methods: Medical data of the patients, who had undergone kidney transplantation (KT) between November 2010 and December 2020, were retrospectively reviewed. Inclusion criteria were adult kidney recipients, who had died. Exclusion criteria were pediatric recipients, recipients of en bloc and dual KT, recipients with missing data, and recipients with a primary non-functioning graft. The recipients were grouped according to their donor type; Group 1 (from a living donor) and Group 2 (from a deceased donor). Subgroup analyses were done for mortality by time-period post-transplant and for infectious causes of mortality. Results: Of 314 recipients, 35 (11.14%) died. Twenty-nine recipients were included in the study (Group 1: 17 and Group 2: 12). The most common cause of mortality was infection (58.6%), and the second was cardiovascular disease (CVD) (24.1%). Sepsis developed in 29.4% of infection-related deaths, while COVID-19 constituted 23.5% of infection-related deaths. Conclusion: Early diagnosis and treatment of infectious and CVD are important to improve survival in kidney recipients.en_US
dc.identifier.doi10.24875/CIRU.21000300
dc.identifier.endpage179en_US
dc.identifier.issn0009-7411
dc.identifier.issue2en_US
dc.identifier.pmid35349567en_US
dc.identifier.scopus2-s2.0-85127221996en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage172en_US
dc.identifier.urihttps://doi.org/10.24875/CIRU.21000300
dc.identifier.urihttps://hdl.handle.net/11616/100567
dc.identifier.volume90en_US
dc.identifier.wosWOS:000777954400001en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherMexican Acad Surgeryen_US
dc.relation.ispartofCirugia Y Cirujanosen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCardiovascularen_US
dc.subjectCOVID-19en_US
dc.subjectInfectionen_US
dc.subjectKidney transplantationen_US
dc.subjectMortalityen_US
dc.titleMortality after kidney transplantation: 10-year outcomesen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu